Bharat Biotech to conduct Phase 3 trials for COVAXIN

Name: Bharat Biotech to conduct Phase 3 trials for COVAXIN
Uploaded: 2020-10-24T05:40:23+00:00
Duration: 37 s
Channel: Aaj Tak
Description: The Bharat Biotech will be conducting Phase 3 trials for its Covid-19 vaccine candidate, COVAXIN, in 25 centres across India and a total of 26,000 people will be participating in the Phase 3 trials. Watch the video for more details.

Aaj Tak

The Bharat Biotech will be conducting Phase 3 trials for its Covid-19 vaccine candidate, COVAXIN, in 25 centres across India and a total of 26,000 people will be participating in the Phase 3 trials. Watch the video for more details.

Category

Comments

Recommended